SARS-CoV-2 spike protein promotes inflammatory cytokine activation
By A Mystery Man Writer
Description
Background Coronavirus disease 2019 (COVID-19) induces inflammation, autoantibody production, and thrombosis, which are common symptoms of autoimmune diseases, including rheumatoid arthritis (RA). However, the effect of COVID-19 on autoimmune disease is not yet fully understood. Methods This study was performed to investigate the effects of COVID-19 on the development and progression of RA using a collagen-induced arthritis (CIA) animal model. Human fibroblast-like synoviocytes (FLS) were transduced with lentivirus carrying the SARS-CoV-2 spike protein gene in vitro, and the levels of inflammatory cytokine and chemokine expression were measured. For in vivo experiments, CIA mice were injected with the gene encoding SARS-CoV-2 spike protein, and disease severity, levels of autoantibodies, thrombotic factors, and inflammatory cytokine and chemokine expression were assessed. In the in vitro experiments, the levels of inflammatory cytokine and chemokine expression were significantly increased by overexpression of SARS-CoV-2 spike protein in human FLS. Results The incidence and severity of RA in CIA mice were slightly increased by SARS-CoV-2 spike protein in vivo. In addition, the levels of autoantibodies and thrombotic factors, such as anti-CXC chemokine ligand 4 (CXCL4, also called PF4) antibodies and anti-phospholipid antibodies were significantly increased by SARS-CoV-2 spike protein. Furthermore, tissue destruction and inflammatory cytokine level in joint tissue were markedly increased in CIA mice by SARS-CoV-2 spike protein. Conclusions The results of the present study suggested that COVID-19 accelerates the development and progression of RA by increasing inflammation, autoantibody production, and thrombosis. Video Abstract
SARS-CoV-2 and Its Implications for the Human Reproductive System: A Review Article, Nephro-Urology Monthly
SARS-CoV-2 Spike S1 glycoprotein is a TLR4 agonist, upregulates ACE2 expression and induces pro-inflammatory M1macrophage polarisation - Abstract - Europe PMC
Signalling strength determines proapoptotic functions of STING
Chondrocyte viability images obtained on days 8, 16, and 24 in a
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic; Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage
Inflammasome activation in infected macrophages drives COVID-19 pathology
T cell-intrinsic STING is critical for antitumor immunity. (A, B
SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis
Multivariate adjustment using the Poisson model for emergency care
FOXP3 Antibody PE 12-5773-82 from Thermo Fisher Scientific
Extracellular vesicles: A promising therapy against SARS-CoV-2 infection: Molecular Therapy
SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production - ScienceDirect
PDF) SARS-CoV-2 spike protein promotes inflammatory cytokine
CXCL4/PF4 ELISA DY595 from R&D Systems, a Bio-Techne Brand
FOXP3 Monoclonal Antibody (FJK-16s), PE-eFluor™ 610 (61-5773-82)
from
per adult (price varies by group size)